Adam Reeves
Research Editor, Eppix Labs · US research library
- Articles
- 53
Scope of the role
- Writes the compound profiles for US laboratories: a summary of what peer-reviewed studies have reported for each peptide, where that evidence stops, and bracketed citations that resolve to PubMed or the source document.
- Covers certificate checking from the bench side — what an HPLC result can and cannot establish, why purity and fill quantity are separate measurements, and how to confirm a report with the laboratory that issued it instead of trusting a screenshot.
- Follows FDA material that touches research peptides, including the 2026 compounding advisory committee review, and ties each regulatory statement to the document it comes from.
This profile covers what the role involves. A personal background will appear here only once it has been provided and can be stood behind.
Rules the byline follows
- Literature claims are numbered against a References list, and each entry leads to PubMed or the original document.
- Lot figures come from the published lab-results library, so an article and the certificate it cites show the same numbers.
- An FDA position is quoted with the document it comes from, since agency positions change.
- Published findings are kept apart from open questions. Laboratory research use only: nothing on dosing or administration.
Published by Adam
- How to Vet a US Research Peptide Supplier in 2026: A 12-Point ChecklistBuying in the US · Oct 2, 2026
- Cagrilintide and Amylin Receptor Research: From Phase 2 to REDEFINE 1Compound Profiles · Sep 30, 2026
- Retatrutide in 2026: The TRIUMPH Phase 3 Program and What "Investigational" MeansCompound Profiles · Sep 28, 2026
- GLP-1, GIP and Glucagon Receptor Pharmacology: Mono-, Dual- and Triple-Agonist Peptides ComparedComparisons & Bench Methods · Sep 26, 2026
- Tesamorelin as a Research Reference: What an FDA-Approved GHRH Analog Tells Us About the ClassCompound Profiles · Sep 25, 2026
- Semax Research in the US: An ACTH(4-10) Analog After the 2026 PCAC VoteCompound Profiles · Sep 23, 2026
- Epitalon and Telomerase Research: What the Studies Show and How to Verify Your MaterialCompound Profiles · Sep 21, 2026
- GHK-Cu Research: Copper Complexation, Gene-Expression Data and the US Route QuestionCompound Profiles · Sep 19, 2026
- MOTS-c Research Primer: A Mitochondrial-Encoded Peptide After the 2026 PCAC ReviewCompound Profiles · Sep 17, 2026
- TB-500 vs Thymosin Beta-4 vs Ac-SDKP: Three Molecules Sold Under One NameComparisons & Bench Methods · Sep 15, 2026
- BPC-157 in the US, 2026: Regulatory Status and What the Preclinical Literature SupportsCompound Profiles · Sep 14, 2026
- BPC-157 vs TB-500: The Research ComparisonComparisons & Bench Methods · Sep 13, 2026
- TB-500 in the US: Synthetic Thymosin β4, Tested by BatchCompound Profiles · Sep 13, 2026
- Peptide Reconstitution Math for the Lab: Concentration, Molarity, Dilution and Aliquots (Worked Examples)Comparisons & Bench Methods · Sep 12, 2026
- Shipping and Storing Lyophilized Peptides in the US: Heat, Transit Time and What to Do on ArrivalComparisons & Bench Methods · Sep 10, 2026
- Endotoxin Testing for Research Peptides: LAL, rFC and What an EU/mg Result MeansVerification & Lab Data · Sep 8, 2026
- How to Read a Janoshik Certificate of Analysis: A Line-by-Line Guide for US LabsVerification & Lab Data · Sep 6, 2026
- HPLC Purity vs Net Peptide Content: Why a 99% Pure Vial Isn't 99% PeptideVerification & Lab Data · Sep 4, 2026
- 503A vs 503B vs RUO: The Three US Peptide Supply Chains, ComparedFDA & Regulation · Sep 3, 2026
- What "Research Use Only" Actually Means in the US After the 2026 FDA Warning LettersFDA & Regulation · Sep 1, 2026
- The July 2026 FDA PCAC Peptide Vote: What It Does and Doesn't Change for US ResearchersFDA & Regulation · Aug 30, 2026
- FDA's April 2026 Category 2 Removals Explained: 12 Peptides, Zero ApprovalsFDA & Regulation · Aug 28, 2026
- How to Verify a Peptide COA in Three StepsVerification & Lab Data · Aug 27, 2026
- How to Spot a Fake Peptide COA: Seven Red FlagsVerification & Lab Data · Aug 27, 2026
- Janoshik Testing Explained: How Every Eppix Batch Is VerifiedVerification & Lab Data · Aug 27, 2026
- Peptide Reconstitution: The Laboratory GuideComparisons & Bench Methods · Aug 27, 2026
- Peptide Storage and Shelf Life: The Laboratory GuideComparisons & Bench Methods · Aug 27, 2026
- Are Peptides Legal in the US? A Plain-Language OverviewFDA & Regulation · Aug 27, 2026
- How to Choose a Peptide Supplier in the US: A Nine-Point ChecklistBuying in the US · Aug 27, 2026
- Retatrutide vs Tirzepatide: Triple Against DualComparisons & Bench Methods · Aug 27, 2026
- Semaglutide vs Tirzepatide: The Only Head-to-Head Trial in the ClassComparisons & Bench Methods · Aug 27, 2026
- BPC-157 in the US: Purity, Batch Certificates and What to CheckCompound Profiles · Aug 27, 2026
- Retatrutide in the US: The Triple Agonist, and What Is Actually PublishedCompound Profiles · Aug 27, 2026
- Tirzepatide in the US: Research-Grade, and How It Differs From the Pharmacy ProductCompound Profiles · Aug 27, 2026
- Semaglutide in the US: Research-Grade, Verified by BatchCompound Profiles · Aug 27, 2026
- GHK-Cu in the US: The Copper Peptide, and Why the Copper Is the Hard PartCompound Profiles · Aug 27, 2026
- CJC-1295 and Ipamorelin in the US: The Blend, and What Each Half DoesCompound Profiles · Aug 27, 2026
- MOTS-c in the US: The Mitochondrial-Derived PeptideCompound Profiles · Aug 27, 2026
- NAD+ in the US: The Coenzyme, Not a PeptideCompound Profiles · Aug 27, 2026
- KPV in the US: The α-MSH Fragment in Inflammation ResearchCompound Profiles · Aug 27, 2026
- Ipamorelin in the US: The Selective SecretagogueCompound Profiles · Aug 27, 2026
- Tesamorelin in the US: The GHRH Analog With Approved-Drug DataCompound Profiles · Aug 27, 2026
- Cagrilintide in the US: The Long-Acting Amylin AnalogCompound Profiles · Aug 27, 2026
- Selank in the US: The Tuftsin Analog From the Russian LiteratureCompound Profiles · Aug 27, 2026
- Epitalon in the US: The Telomerase Claim, ExaminedCompound Profiles · Aug 27, 2026
- Sermorelin in the US: GHRH(1-29), and the Approval That Was WithdrawnCompound Profiles · Aug 27, 2026
- Thymosin Alpha-1 in the US: The Immune Peptide With Real Approvals ElsewhereCompound Profiles · Aug 27, 2026
- 5-Amino-1MQ in the US: The NNMT Inhibitor That Is Not a PeptideCompound Profiles · Aug 27, 2026
- Eloralintide in the US: The Selective Amylin AgonistCompound Profiles · Aug 27, 2026
- Purity vs Fill Accuracy: Why One Number Is Not EnoughVerification & Lab Data · Aug 24, 2026
- How to Read a Certificate of AnalysisVerification & Lab Data · Aug 24, 2026
- Tirzepatide: A Research Literature OverviewCompound Profiles · Jul 31, 2026
- BPC-157: A Research Literature OverviewCompound Profiles · May 29, 2026